Diabetes
101 articles
Let’s Win Lunch and Learn: Pancreatic Cancer and Diabetes
In a special Lunch and Learn webinar, doctors and diabetes educators discuss the relationship between pancreatic cancer and diabetes.
The Future of Pancreatic Cancer Treatment
Dr. Anil Rustgi discusses the latest developments in pancreatic cancer treatment and the direction of current research in early detection.
Not Just a Survivor . . . A Sur-thriver!
Jon Oelke found that he has a rare genetic mutation, which gives him a back-up plan for treatment if his initial chemo stops working.
More Info = Less Fear
Dwayne Montgomery traveled to MD Anderson for a second opinion but the doctors there told him about an expert Whipple surgeon in his hometown.
Always Insist On More
Dave Paffenroth’s wife Wendy was an extraordinary caregiver, coordinating treatments and family support during pancreatic cancer treatment.
AACR Annual Meeting 2021 Highlights
Let’s Win and the Lustgarten Foundation bring you the pancreatic cancer research highlights of the 2021 AACR Annual Meeting,
Developing a Screening Test for Pancreatic Cancer
One focus of research for Dr. Anirban Maitra is to develop a simple screening test for pancreatic cancer, to provide an earlier diagnosis of the disease.
Five Promising Researchers Leading the Charge in Treatment Advancements
Meet the five promising researchers supported by Let’s Win at the 2023 AACR Special Conference on Research: Pancreatic Cancer.
Why Pancreatic Cancer Can Mess with Your Blood Sugar (and What to Do About It)
Nurse and diabetes educator Linda Nguyen provides tips for managing blood sugar levels in pancreatic cancer patients.
Going Outside Standard Protocol Changed Everything
Sharon Rockmaker was determined to have a Whipple procedure despite having stage IV pancreatic cancer, and she finally did.
Pancreatic Cancer Science—2021 in Review
As the year winds down Let’s Win provides an overall look at the highlights of 2021 in pancreatic cancer science.
Pancreatic Cancer Research Builds Upon Strengths
The September 2023 AACR Special Conference on Pancreatic Cancer focused on the latest research in KRAS, chemotherapy, and cachexia, among other topics.
Reducing Pancreatic Cancer Disparities Through the NCI Community Oncology Research Program (NCORP)
The NCI’s Community Oncology Research Program (NCORP) aims to reduce cancer disparities among the underserved by giving everyone access to clinical trials.
Why Side Effect Management Matters More Than Ever
As an endo-oncologist, Dr. Afreen Shariff knows the importance of side effects in pancreatic cancer patients.
The Benefit of Multiple Clinical Trials
Dr. Ira Sharp knew that his best bet for surviving pancreatic cancer was to look for clinical trials as part of his treatment.